Pedskin Research pediatric skin diseases

Treatment of Vitiligo

Is your child experiencing light or white patches on their skin?

Children with non-segmental Vitiligo may qualify for participation in an ongoing clinical trial.

About the Treatment

This study is a randomized, double-blind trial assessing ruxolitinib 1.5% cream in children aged 2 to under 12 with non-segmental vitiligo. About 180 participants will be randomized to receive either the cream or a vehicle control, with treatment lasting 24 weeks followed by a 28-week open-label extension for those without safety concerns, consisting of 6 clinic visits every six weeks. Of the six visits, five will require blood draws. Participants will apply the cream twice daily to affected areas, with a maximum application of 10% body surface area (BSA). The total study duration for each participant is approximately 14 months, including screening, treatment, and a follow-up visit 30 days after treatment completion.

  • Pediatric study (ages 2-11) testing Ruxolitinib (Opzelura) 1.5% cream.

  • Adult study testing Povorcitinib (oral JAK1 inhibitor), specifically recruiting for African American patients.

Learn more about this treatment and see if your child is a candidate.

Pedskin Research pediatric dermatology

Request an Appointment

To request an appointment, please fill out the contact form below. Our team will get back to you as soon as possible to confirm your appointment and answer any questions you may have.

We look forward to assisting you.

Vitiligo
Opt-In

Meet Our Medical Director

Mercedes E. Gonzalez M.D.
Mercedes E. Gonzalez M.D.

Dr. Mercedes E. Gonzalez is a board-certified pediatric dermatologist. After graduating from Emory University, she earned her degree at Rutgers–New Jersey Medical School in 2004. Always drawn to working with children, she accepted the prestigious pediatrics program at the Morgan Stanley Children’s Hospital of New York–Columbia University where she solidified her interest in treating skin disorders. She then completed a dermatology residency followed by a clinical fellowship in pediatric dermatology at the top-ranked New York University (NYU) Department of Dermatology.

Her gentle, child-friendly bedside manner, combined with her broad knowledge of childhood skin diseases and their treatments, make her the preferred pediatric dermatologist in Miami. In addition to practicing medicine, Dr. Gonzalez currently serves as a clinical assistant professor at The FIU Herbert Wertheim School of Medicine and The Phillip Frost Department of Dermatology at Miller School of Medicine.

Dr. Gonzalez serves as the principal investigator on numerous clinical trials and has a special interest in severe skin diseases in children. She lectures regularly at dermatology conferences and to medical students and residents and is the co-editor of 3 dermatology textbooks, including the recently published 2nd edition of Goodheart’s Same Site Differential Diagnosis, and has published over 50 journal articles.

  • Board-certified pediatric dermatologist.

  • Graduated from Emory University.

  • Earned her degree at rutgers–New Jersey Medical School in 2004.

  • Dr. Gonzalez accepted the prestigious pediatrics program at the Morgan Stanley Children’s Hospital of New York–Columbia University where she solidified her interest in treating skin disorders.

  • She then completed a dermatology residency at the top-ranked New York School of Medicine, followed by a clinical fellowship in pediatric dermatology.

Pedskin Research treatment for skin conditions

Frequently Asked Questions

Vitiligo is a skin condition where the immune system attacks pigment-producing cells in the skin, causing white patches on the skin.

It is an autoimmune disorder, but genetic and environmental factors may also contribute to its development.

No, vitiligo is not contagious and cannot be spread through contact.

Yes, vitiligo can spread, but the rate and pattern vary for each child.

Vitiligo itself is not harmful, but it may be linked to other autoimmune conditions.

We offer treatments such as topical creams, phototherapy, and clinical research trials offering the latest breakthroughs in vitiligo therapy.

Some treatments may restore pigment in certain areas, but results vary.

Sunscreen is essential, as affected areas are more prone to sunburn and damage.

Yes, stress can worsen any skin disease.

Some children may experience self-esteem issues. Emotional support and counseling can help them cope.